Hormone therapy in prostate cancer: Moving into the 21st century

European Urology, Supplements

Volumn 4, Issue 4 SPEC. ISS., 2005, Pages 53-56

  Whelan, Peter ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; ANTINEOPLASTIC AGENT; ESTROGEN; GONADORELIN; GONADORELIN AGONIST; PROSTATE SPECIFIC ANTIGEN;

ADVANCED CANCER; BIOCHEMISTRY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; METASTASIS; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; PROSTATE CANCER; SIDE EFFECT; SURVIVAL RATE; TREATMENT FAILURE;

EID: 13544265303     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2005.01.002     Document Type: Conference Paper

References (13)

1. S.H. Landis, T. Murray, S. Bolden, and P.A. Wingo Cancer statistics, 1999. CA Cancer J Clin 49 1999 8 31
2. L.K. Dennis, and M.I. Resnick Analysis of recent trends in prostate cancer incidents and mortality Prostate 42 2000 247
3. D.C. Smith, B.G. Redmond, and R. Flaherty A phase II trial of oral diethyloesterol as a second line hormonal agent in advanced prostate cancer Urology 52 1988 257
4. P. Iverson Orchidectomy and oestrogen therapy revisited Eur Urol 34 Suppl 1998 7
5. S.C. Goldenberg, N. Bruchovsky, and M.E. Gleave Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report J Urol 157 Suppl 1997 390
6. W. Albrecht, L. Collette, C. Fava, O.B. Kariakine, P. Whelan, and U.E. Struder Intermittent maximal androgen blockade in patients with metastatic prostate cancer. An EORTC feasibility study Eur Urol 44 2003 505 511
7. M. Bolla, D. Gonzalez, and P. Warde Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin N Engl J Med 337 1997 295
8. M.V. Pilepich, K. Winter, and M.J. John Phase III radiation therapy Oncology Group (RTOG) trial 86-10 of androgen depravation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate Int J Radiat Oncol Biol Phys 50 2001 1243
9. P. Iverson, C.L. Tyrrell, and A.V. Kaisery Bicalutamide monotherapy compared with castration in patients with locally advanced prostate cancer. 6.3 years of follow up J Urol 164 2000 159
10. M.L. Blute, E.J. Bergstralch, and A. Iocca Use of Gleason score, prostate specific antigen seminal vessels and margin status to predict biochemical failure after radical prostatectomy J Urol 165 2001 119
11. C.R. Pound, A.W. Partin, and M.A. Eisenberger National history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591
12. M.S. Litwin, C.S. Saigal, and D.P. Lubeck Health-related quality of life in men with metastatic prostate cancer: the misleading effect of lead time bias BJU Int 91 2003 9
13. C. Huggins, and C.V. Hodges Studies in prostate Cancer: effect of castration, oestrogen's and or androgen injection on serum phosphatase in metastatic carcinoma of the prostate Cancer Res 1 1941 293